Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

9.8K
9.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans.

Cells·2025
Same author

Incidence, risk factors, and prognostic impact of regional lymph node metastasis in bone sarcoma: a population-based cohort study.

Japanese journal of clinical oncology·2025
Same author

Incidence and age- and site-specific characteristics of osteosarcoma: a population-based study using National Cancer Registry 2016-2019.

Japanese journal of clinical oncology·2025
Same author

Osteosarcoma in Japan: report from the bone and soft tissue tumor registry 2006-2022.

Japanese journal of clinical oncology·2025
Same author

The prognostic factors and treatment patterns of the first recurrence of retroperitoneal liposarcoma.

International journal of clinical oncology·2025
Same author

Establishment and characterization of NCC-MLPS4-C1: a novel patient-derived cell line of myxoid liposarcoma.

Human cell·2025

Related Experiment Video

Updated: May 3, 2026

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
05:16

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells

Published on: December 30, 2025

485

MicroRNA expression and functional profiles of osteosarcoma.

Eisuke Kobayashi1, Reiko Satow, Masaya Ono

  • 1Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, Tokyo, Japan.

Oncology
|January 25, 2014
PubMed
Summary

The let-7 family of microRNAs (miRNAs) significantly suppresses osteosarcoma cell proliferation. These miRNAs also regulate proteins involved in cell growth, offering potential new therapeutic targets for osteosarcoma treatment.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

6.7K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

8.4K

Related Experiment Videos

Last Updated: May 3, 2026

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
05:16

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells

Published on: December 30, 2025

485
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

6.7K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

8.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma (OS) is a primary bone cancer common in children and young adults.
  • While chemotherapy improves survival, outcomes for poor responders remain unfavorable.
  • New therapeutic strategies require understanding OS cell proliferation pathways.

Purpose of the Study:

  • To investigate the role of microRNAs (miRNAs) in osteosarcoma (OS) cell proliferation.
  • To identify specific miRNAs involved in OS pathogenesis.
  • To explore potential miRNA-based therapeutic targets for OS.

Main Methods:

  • Utilized miRNA microarrays to analyze 933 miRNAs in 24 OS tissue samples.
  • Conducted cell proliferation assays on OS cells.
  • Employed quantitative shotgun proteomics to identify protein targets of specific miRNAs.

Main Results:

  • Identified 108 commonly expressed miRNAs in OS tissues.
  • Demonstrated that inhibiting five let-7 family miRNAs (hsa-let-7a, b, f, g, i) significantly suppressed OS cell proliferation.
  • Found that let-7 family miRNAs regulate vimentin and serpin H1 protein expression.

Conclusions:

  • The let-7 family of miRNAs is implicated in regulating osteosarcoma cell proliferation.
  • let-7 family miRNAs are involved in the epithelial-mesenchymal transition of OS cells.
  • let-7 family miRNAs represent promising novel targets for developing therapeutic strategies against osteosarcoma.